Chagas disease
A Rassi, JA Marin-Neto - The Lancet, 2010 - thelancet.com
Chagas disease is a chronic, systemic, parasitic infection caused by the protozoan
Trypanosoma cruzi, and was discovered in 1909. The disease affects about 8 million people …
Trypanosoma cruzi, and was discovered in 1909. The disease affects about 8 million people …
Chagas' disease
HB Tanowitz, LV Kirchhoff, D Simon… - Clinical microbiology …, 1992 - Am Soc Microbiol
Chagas' disease, caused by Trypanosoma cruzi, is an important cause of morbidity in many
countries in Latin America. The important modes of transmission are by the bite of the …
countries in Latin America. The important modes of transmission are by the bite of the …
II Consenso Brasileiro em doença de Chagas, 2015
JCP Dias, AN Ramos Jr, ED Gontijo… - … e Serviços de …, 2016 - SciELO Public Health
RESUMO A doença de Chagas é uma condição crônica negligenciada com elevada carga
de morbimortalidade e impacto dos pontos de vista psicológico, social e econômico …
de morbimortalidade e impacto dos pontos de vista psicológico, social e econômico …
[HTML][HTML] 2 nd Brazilian Consensus on Chagas Disease, 2015
JCP Dias, AN Ramos Jr, ED Gontijo… - Revista da Sociedade …, 2016 - SciELO Brasil
Chagas disease is a neglected chronic condition with a high burden of morbidity and
mortality. It has considerable psychological, social, and economic impacts. The disease …
mortality. It has considerable psychological, social, and economic impacts. The disease …
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial
CA Morillo, H Waskin, S Sosa-Estani… - Journal of the American …, 2017 - jacc.org
Background: Benznidazole is recommended for treatment of Chagas infection. Effects of
combination therapy with benznidazole and posaconazole have not been tested in …
combination therapy with benznidazole and posaconazole have not been tested in …
International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
AG Schijman, M Bisio, L Orellana, M Sued… - PLoS neglected …, 2011 - journals.plos.org
Background A century after its discovery, Chagas disease still represents a major neglected
tropical threat. Accurate diagnostics tools as well as surrogate markers of parasitological …
tropical threat. Accurate diagnostics tools as well as surrogate markers of parasitological …
Translational challenges of animal models in Chagas disease drug development: a review
E Chatelain, N Konar - Drug design, development and therapy, 2015 - Taylor & Francis
Chagas disease, or American trypanosomiasis, caused by Trypanosoma cruzi parasite
infection is endemic in Latin America and presents an increasing clinical challenge due to …
infection is endemic in Latin America and presents an increasing clinical challenge due to …
Cardiac involvement with parasitic infections
A Hidron, N Vogenthaler… - Clinical Microbiology …, 2010 - Am Soc Microbiol
Parasitic infections previously seen only in developing tropical settings can be currently
diagnosed worldwide due to travel and population migration. Some parasites may directly or …
diagnosed worldwide due to travel and population migration. Some parasites may directly or …
Chagas disease and stroke
FJ Carod-Artal, J Gascon - The Lancet Neurology, 2010 - thelancet.com
Chagas disease is a neglected infectious disease in the tropics and an emerging health
problem in Europe and the USA. In the past decade, a link has been recorded between …
problem in Europe and the USA. In the past decade, a link has been recorded between …
[HTML][HTML] Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease …
OC Moreira, JD Ramírez, E Velázquez, MFAD Melo… - Acta Tropica, 2013 - Elsevier
Quantitative real-time PCR (qPCR) is an accurate method to quantify Trypanosoma cruzi
DNA and can be used to follow-up parasitemia in Chagas disease (CD) patients undergoing …
DNA and can be used to follow-up parasitemia in Chagas disease (CD) patients undergoing …